| Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses H Pan, R Peto, AMH Restrepo, MP Preziosi, V Sathiyamoorthy, QA Karim, ... The Lancet 399 (10339), 1941-1953, 2022 | 253 | 2022 |
| Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial K Ali, T Azher, M Baqi, A Binnie, S Borgia, FM Carrier, YA Cavayas, ... Cmaj 194 (7), E242-E251, 2022 | 153 | 2022 |
| Dysregulation of ACE (angiotensin-converting enzyme)-2 and renin-angiotensin peptides in SARS-CoV-2 mediated mortality and end-organ injuries K Wang, M Gheblawi, A Nikhanj, M Munan, E MacIntyre, C O’Neil, ... Hypertension 79 (2), 365-378, 2022 | 69 | 2022 |
| Factors associated with antiretroviral medication adherence among HIV-positive adults accessing highly active antiretroviral therapy (HAART) in British Columbia, Canada CR O’Neil, AK Palmer, S Coulter, N O’Brien, A Shen, W Zhang, ... Journal of the International Association of Physicians in AIDS Care 11 (2 …, 2012 | 59 | 2012 |
| Galectin-9, a player in cytokine release syndrome and a surrogate diagnostic biomarker in SARS-CoV-2 infection N Bozorgmehr, S Mashhouri, E Perez Rosero, L Xu, S Shahbaz, W Sligl, ... MBio 12 (3), 10.1128/mbio. 00384-21, 2021 | 58 | 2021 |
| ISARIC-COVID-19 dataset: a prospective, standardized, global dataset of patients hospitalized with COVID-19 M Etienne, N Ettalhaoui, AG Everding, M Evers, I Fabre, M Fabre, ... Scientific data 9 (1), 454, 2022 | 37 | 2022 |
| The value of open-source clinical science in pandemic response: lessons from ISARIC A Abbas, SA Abdukahil, NN Abdulkadir, R Abe, L Abel, L Absil, S Acharya, ... The Lancet infectious diseases 21 (12), 1623-1624, 2021 | 37 | 2021 |
| Bone and Joint Infections due to Haemophilus parainfluenzae: Case Report and Review of the Literature CR O’Neil, E Wilson, B Missaghi Canadian Journal of Infectious Diseases and Medical Microbiology 2016 (1 …, 2016 | 22 | 2016 |
| Canadian Treatments for COVID-19 (CATCO); Association of Medical Microbiology and Infectious Disease Canada (AMMI) Clinical Research Network and the Canadian Critical Care … K Ali, T Azher, M Baqi, A Binnie, S Borgia, FM Carrier, YA Cavayas, ... CMAJ 194 (7), E242-E251, 2022 | 18 | 2022 |
| The effects of trained observers (dofficers) and audits during a facility-wide COVID-19 outbreak: a mixed-methods quality improvement analysis C Picard, M Edlund, C Keddie, L Asadi, D O'Dochartaigh, R Drew, ... American Journal of Infection Control 49 (9), 1136-1141, 2021 | 15 | 2021 |
| Differential signature of the microbiome and neutrophils in the oral cavity of HIV-infected individuals E Perez Rosero, S Heron, J Jovel, CR O’Neil, SL Turvey, P Parashar, ... Frontiers in immunology 12, 780910, 2021 | 14 | 2021 |
| Achievement of hepatitis C cascade of care milestones: a population-level analysis in Alberta, Canada CR O’Neil, E Buss, S Plitt, M Osman, CS Coffin, CL Charlton, S Shafran Canadian Journal of Public Health 110, 714-721, 2019 | 12 | 2019 |
| Mycobacterium chimaera Infection After Aortic Valve Replacement Presenting With Aortic Dissection and Pseudoaneurysm CR O’Neil, G Taylor, S Smith, AM Joffe, K Antonation, S Shafran, ... Open Forum Infectious Diseases 5 (2), ofy018, 2018 | 9 | 2018 |
| Association of country income level with the characteristics and outcomes of critically ill patients hospitalized with acute kidney injury and COVID-19 M Wainstein, N Spyrison, D Dai, M Ghadimi, JS Chávez-Iñiguez, ... Kidney international reports 8 (8), 1514-1530, 2023 | 7 | 2023 |
| Long-term follow-up and quantitative hepatitis B surface antigen monitoring in North American chronic HBV carriers CR O’Neil, SE Congly, MS Rose, SS Lee, MA Borman, CL Charlton, ... Annals of Hepatology 17 (2), 232-241, 2018 | 7 | 2018 |
| Association of Medical Microbiology and Infectious Disease Canada (AMMI) Clinical Research Network and the Canadian Critical Care Trials Group. Remdesivir for the treatment of … K Ali, T Azher, M Baqi, A Binnie, S Borgia, FM Carrier, YA Cavayas, ... CMAJ 194 (7), E242-E251, 2022 | 5 | 2022 |
| Cost-effectiveness of remdesivir plus usual care versus usual care alone for hospitalized patients with COVID-19: an economic evaluation as part of the Canadian Treatments for … VI Lau, R Fowler, R Pinto, A Tremblay, S Borgia, FM Carrier, MP Cheng, ... Canadian Medical Association Open Access Journal 10 (3), E807-E817, 2022 | 4 | 2022 |
| Treatment Outcomes with Telaprevir‐Based Therapy for HIV/Hepatitis C Coinfected Patients are Comparable with Hepatitis C Monoinfected Patients CR O’Neil, JXQ Pang, SS Lee, MG Swain, KW Burak, P Klein, RP Myers, ... Canadian Journal of Infectious Diseases and Medical Microbiology 26 (6), 293-296, 2015 | 3 | 2015 |
| One lab finding, 2 vastly different causes. CR O'Neil, S Fanella The Journal of Family Practice 65 (10), 715-718, 2016 | 1 | 2016 |
| Dynamics of serum quantitative hepatitis B surface antigen testing in assessing nucleos/tide analog treatment response and disease phenotype in chronic hepatitis B patients in … CR O’Neil, SE Congly, SS Lee, M Borman, CL Charlton, C Osiowy, ... Journal of Hepatology 2 (64), S356, 2016 | 1 | 2016 |
